2023-03-31-accounts - The Hepatitis C Trust

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

THE HEPATITIS C TRUST Working together to eliminate hepatitis C

ANNUAL REPORT & ACCOUNTS 2023

The Hepatitis C Trust Annual Report 2023

O U R M I S S I O N

THE HEPATITIS C TRUST IS DEDICATED TO ELIMINATING HEPATITIS C IN THE UK BY 2030 ●

WORKING ALONGSIDE OUR PARTNERS, WE ARE COMMITTED TO ENSURING THAT NO ONE IS LEFT BEHIND ON THE ROAD TO ELIMINATION ●

CONTENT

TRUSTEES’ REPORT

Our mission	2
Our focus	4
Letter from the CEO & Trustees	6
Theyear in numbers	8
Financial overview	10
ACHIEVEMENTS AND PERFORMANCE
Leavingno one behind in the community	12
Leavingno one behind inprisons	16
Trainingto make sure no one is left behind	20
Support for the infected blood community	24
World Hepatitis Day2022	28
Keepinghepatitis C elimination on thepolitical agenda	30
Keepingthe hepatitis Cprofessional communityinformed and connected	34
Art On a Postcard	38
Governance and management	40
Financial review	42
INDEPENDENT AUDITOR’S REPORT
Financial statement	44

OUR FOCUS

More than 20 years later, we have grown from a small organisation to one of more than 150 permanent staff and more than 150 peer volunteers. This includes large on the ground peer-to- peer programmes in both the community and prisons, working across 23 NHS Operational Delivery Networks (ODNs) and 128 prisons.

The Hepatitis C Trust is a charity dedicated to eliminating hepatitis C in the UK by 2030.

We champion the right of every person at risk of hepatitis C in the UK to receive effective testing, treatment and care.

We achieve this by empowering people with lived experience, influencing policy and practice, and working with healthcare and treatment services to deliver support and raise awareness about hepatitis C.

We remain a peer-led organisation, which means that the majority of our staff and volunteers have been affected by hepatitis C. Our combined lived experience ensures that the patient’s voice remains at the heart of everything we do.

The Hepatitis C Trust was founded in 2001 by four people who met while looking for ways to manage their condition. At that time, there was no effective treatment for hepatitis C and there was no central source for reliable information about the virus.

OUR STRATEGY

Our strategy is focused around the pillars of better prevention and more diagnosis and treatment for all. With an elimination deal in place with UK governments, and our peer programmes reaching across communities and prisons in the UK, we are currently working to identify and engage both those undiagnosed and those diagnosed but untreated.

Determined to do something, these founders formed the UK’s first and only dedicated hepatitis C charity.

“ We couldn’t do what we do without The Hepatitis C Trust and our peer volunteers. Through lived experience, they are able gain the patient’s trust and help them to engage with our service.”

WHAT IS HEPATITIS C?

Hepatitis C (HCV) is a virus passed via bloodto-blood contact that infects the liver. If left untreated, it can cause cirrhosis, liver cancer, and liver failure.

With treatment, 97% of patients are cured of the virus after just a few months.

EMMA ARNOLD, LEAD CLINICAL NURSE SPECIALIST, LEICESTER’S HOSPITALS

The Hepatitis C Trust Annual Report 2023 | Trustees’ Report

F O R E W O R D

LETTER FROM THE CEO & TRUSTEES ●

As we reflect over the past year, we’re both proud of our achievements and enthused by the NHS England announcement that we’re set to reach the World Health Organization (WHO) elimination targets ahead of 2030. Alongside these encouraging outcomes, the UK applied to and was accepted by WHO to become a pilot elimination country, one of only 10 across the world.

Seeing COVID-19 restrictions subside this year and the reintroduction of face-to-face meetings and larger events has offered a new invigorated energy. Internally we have strengthened our core structure bringing in a new Head of Communications role which has allowed us to increase our social media visibility and develop an exciting new website.

Our focus on reaching those hardest to engage and ensuring no one is left behind has remained at the centre of our work, along with maintaining a high level of awareness raising and proactively driving harm reduction; particularly the availability of adequate needle and syringe provision for all.

Building on the reputation and success of our peer programme, new funding opportunities, including with NHS Cancer Alliances, have allowed the Community Peer Programme to continue to grow and expand its reach. This year we worked within or led on several new innovative programmes including Liver Surveillance, Emergency Department testing and a national South Asian programme.

Partnership working has once more been key to achieving our outcomes. An example of which has been our partnership work with drug services and pharmacies across England to support NHS England Needs Assessment, with over 10,000 people being tested within these services. A focused piece of work to demonstrate the rate of new HCV infections, this will need to be completed again next year as part of the WHO criteria for elimination.

Although continued restrictions posed some challenges across the prison estate, we still managed to maintain a high level of peer programme activities, including the delivery of High Intensity Test and Treat programmes across 19 prisons − testing on average 95% of each individual prison population. Our work within the wider criminal justice system has continued to reach beyond the prison gate with the prison peer programme expanding to the community including in approved premises and probation services.

We broadened our Information and Support services offer this year by holding regular online support groups for members of the infected blood community, alongside our national helpline.

It has been a challenge for our small but dedicated team to keep up with the volume of calls we receive, particularly from those impacted by the infected blood scandal. The publication of the second interim report, which focused on the framework for compensation, significantly increased the need for support.

To ensure best practice and for our resources to meet demand we have continued to invest in our incredible pool of volunteers through our training programmes. To date more than 33% of our new staff recruitment comes from our volunteer pool; something we’re very proud of.

We launched an exciting new work stream, HCT Research, at the beginning of the year. The Trust has long been an active partner in academic research into hepatitis C, as well as a key organisation in developing new models of diagnosis, treatment, and care. Our goal is to bring these parts of our work more closely together, strengthen them, and take a more active role in setting and delivering the hepatitis C research agenda. Our work has included both taking part and leading on core pieces of research including looking at the Community peer model how and why it works. Our submission of abstracts to conferences on our unique peer programmes has led to recognition and presentations by our staff team both local and globally.

We maintained our policy and parliamentary work across the devolved nations throughout the year. Engaging with ministers in Scotland, organising a Senedd (Welsh Parliament) drop-in event and providing briefings and Written Questions in support of parliamentary activity to keep hepatitis C elimination firmly on the agenda. We also hosted a World Hepatitis Day parliamentary reception, which brought together 120 people, including staff, NHS workers and others to meet with parliamentarians to celebrate all that has

been achieved so far in tackling hepatitis C, and to galvanise those involved to continue to work towards the target of eliminating hepatitis C by NHS England’s 2025 target.

With the prominent recognition of the elimination programme achievements, we worked in partnership with HCV Action to publish the report, ‘Taking the initiative: how England is eliminating hepatitis C’. The report explores the development of England’s hepatitis C elimination programme since 2019.

As we look forward to next year, which is the final year of NHS England’s five year elimination programme, we are mindful that there is still much to be done if we’re to reach elimination and ensure maintenance is in place once it’s achieved. We’re hopeful that there will be an extension to this unique programme which will allow the UK to not only reach elimination but to ensure ‘No one is left behind’.

We hope you enjoy reading the rest of our report, particularly the impact stories.

The Hepatitis C Trust Annual Report 2023 | Trustees’ Report

THE YEAR IN NUMBERS

30,904 49,239 14 749 , 1,200

people in the community tested for hepatitis C

people engaged through hepatitis C awareness sessions or conversations in the community

people in prison tested for hepatitis C at High Intensity Test and Treat events

people supported to start treatment while in prison

116 contacts via the helpline 314

45 5,007

external blood-borne virus professional training events

peer volunteers completed induction training people attended the HCV Action conference in person and online

The Hepatitis C Trust Annual Report 2023 | Trustees’ Report

FINANCIAL OVERVIEW

An overview of our total income and expenditure for this year, with a comparison to that of last year.

----- Start of picture text -----
TOTAL INCOME TOTAL EXPENDITURE
2021-22 2022-23 2021-22 2022-23
Donations £0.21M £0.31M Raising funds £0.17M £0.21M
Investments £336 £0.01M Charitable activities £4.24M £6.3M
Charitable activities £4.78M £6.97M Other income - -
Total £4.99M £7.3M Total £4.44M £6.52M
2022-23
2022-23
2021-22 2021-22
----- End of picture text -----

Achievements and Performance

LEAVING NO ONE BEHIND IN THE COMMUNITY

2022-23 TARGET

To increase our reach to ensure no one is left behind, while working with partners to gather strong data to support elimination.

Our community peer programmes continue to build their reputation as a valued part of NHS care pathways.

INNOVATION

As a result of the success of our programmes, new opportunities arose from funders in 2022. This included NHS Cancer Alliances which support our growing liver cancer work, statutory government sources such as drug and alcohol service commissioners, and individual health boards in Wales.

The year saw further expansion of our staff teams and, although recruitment has been a challenge in some areas, we have managed to fill all posts. Our two new vans took to the open road delivering mobile clinics across Oxfordshire and Leicester and we also provided staff support to several other ODN van clinics. We have a dedicated van team working across North East and South East London to deliver early diagnosis of liver cancer screening programmes. Variations of this model are also being delivered in Wessex and Nottingham. Our South Asian Project team also expanded this year, with additional funding from MSD, enabling us to reach across England. Strong partnership working led to microelimination being achieved at various substance use services. Our team was key in delivering NHS England’s Needs Assessment where 10,000 patients were tested within these services. These same individuals will need to be found next year and tested again so that NHS England can demonstrate the rate of new infections as part of the WHO criteria for elimination.

These are welcome new avenues of work, for which our peer model has a proven record of achievement.

EMERGENCY DEPARTMENT TESTING

We played a key role in the establishment of optout blood-borne virus (BBV) testing in Emergency Departments (ED) across London. This has been a huge development. Now, almost all ED settings in London – as well as Manchester, Blackpool, and Sussex - test everyone requiring blood samples, whatever their reason for their ED visit. Almost 1,700 people were found who had either HIV, hepatitis B or hepatitis C in the first 10 months of this three-year programme.

people engaged through hepatitis C awareness sessions or conversations.


49,239	people engaged through
	hepatitis C awareness sessions
	or conversations.
30,904	people in the community tested
	for hepatitis C this year.
3,240	individuals supported to access

individuals supported to access hepatitis C treatment.

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

S T O R Y O F I M P A C T

BRINGING TREATMENT TO PEOPLE IN NORTH DEVON

Our work in North Devon has always faced

FROM REHAB TO EMPLOYMENT

a number of challenges, including poor public transport systems, staff vacancies at local hospitals and the limited capacity of drug and treatment services.

Our peer volunteer Kevin* found out that he had hepatitis C while he was in rehab for drug addiction.

We supported him through his treatment and once he was cured, he decided that he wanted to give something back to the Trust.

When we met Dave*, he told us that he knew that he had hepatitis C for a long time but had not been turning up to his hospital appointments.

Kevin was extremely motivated by the difference he could see his work was making in people’s lives.

We retested him to confirm the diagnosis and had a conversation with him about the hurdles he faced. From speaking to him, we knew that attending hospital appointments was an impractical option for him. This meant we had to think outside of the box to make sure he could complete treatment.

Having previously been in active addiction in the area where he was working, Kevin knew exactly where we needed to go to find people who needed testing.

After volunteering for 11 months, he applied for a peer job with the NHS.

We decided to bring treatment to Dave. We loaded a van with nurses and equipment and went to meet him. Dave was so grateful that we had addressed his challenges. He started treatment within two weeks and is now cured of the virus. He now hopes to join the team as a peer.

Kevin’s life has been totally turned around since he entered rehab. He loves the work he does and continues to make an invaluable contribution to the NHS team.

We now use this approach in other areas where we have struggled to find venues for testing, or where limited public transport makes treatment a challenge.

The names in these stories have been changed

“ We decided to bring treatment to Dave.”

GOING THE EXTRA MILE: OUR SUPPORT FOR SAM

A local authority referral has since been accepted by a housing provider that delivers round the clock on-site support.

On a visit to A&E, a routine blood test was also

screened for hepatitis C. This test revealed that Sam* had hepatitis C.

Following several failed attempts to contact Sam by St. George’s Hepatology Department, he was referred to us.

Shortly after an initial medical assessment Sam was approved for treatment, although there were some concerns about his ability to comply with the treatment plan. The extent of Sam’s daily alcohol intake is such that no expectation could be placed on him to adhere to the medication regimen alone. It was decided that a peer would take guardianship of Sam’s medication and locate him in the community throughout the week to hand out the doses.

Sam lived at a London hotel that provides housing to local authority adult social services. Our staff and a nurse visited this hotel with the mobile outreach clinic and met with Sam to inform him of the test result.

Sadly, our team discovered that Sam was living in such abject conditions at the hotel that a safeguarding concern for self-neglect needed to be raised with the local authority. Sam gave consent for our staff to contact other organisations that were involved with his case. A meeting was set up with local authority adult social care and others to discuss Sam’s housing needs. Sam was then moved to more suitable temporary accommodation and a package of care was put in place that included daily visits from a care worker.

This was labour intensive work, more often than not resulting in multiple trips around the boroughs of London in a single day to locate Sam. The hard work ultimately paid off as Sam was able to complete the treatment – something which would have been almost impossible for him without support.

The names in these stories have been changed

OUR 2023-24 PRIORITY

› To increase our reach beyond drug services, delivering targeted testing and support for groups not yet reached, alongside expanding the role of peers across wider liver health.

Achievements and Performance

LEAVING NO ONE BEHIND IN PRISONS

2022-23 TARGET

To maintain our case-finding capacity, and increase our reach across the criminal justice system.

This year we maintained our peer work across 104 English prisons, as well as many prisons in Scotland and Wales. To do this we work in partnership with HM Prison and Probation Service, UKHSA, the NHS, health care providers and other charities. Together, we raise awareness, educate and test people at risk of hepatitis C and support those who need it through treatment.

to encourage testing and reduce stigma, alongside offering and delivering testing events across England. In addition, education awareness and testing took place in both immigration centres and forensic service settings.

This engagement enabled us to find 1,200 more cases of hepatitis C within the criminal justice setting, as well as raising awareness of the virus among people who historically may not have engaged in health care services.

We have continued to coordinate High-Intensity Test and Treat (HITT) programmes in individual prisons. These whole prison testing events offer all prisoners the opportunity to be tested for hepatitis C and, where available, other blood-borne viruses. This year, we supported just under 15,000 people across 19 prisons to be tested at HITT events, testing on average 95% of each individual prison population.

* The requirement for micro elimination is that 95% of people in the prison population have been tested within the last 12 months; that 90% of people who have tested positive have started treatment within the last 12 months; that a process is in place for a quarterly review of testing and treatment uptake; and that there is reception testing and direct outreach.

16 prisons have now reached and maintained micro elimination*, including one premises that holds over 1,200 people.

396	Hepatitis awareness training
	sessions delivered for people
	in prison and staf
14,749	people tested for hepatitis C
	at HITT events
1,200	people supported to start
	treatment while in prison

Supporting individual prisons to increase their hepatitis C reception testing has proven very successful this year, with 72% of prisoners agreeing to be tested on arrival.

Following our work with approved premises last year we widened our criminal justice reach within community settings. Building on existing partnership work with local probation services we delivered education and awareness raising

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

S T O R Y O F I M P A C T

LUCY’S HEPATITIS C STORY

Lucy* was diagnosed with hepatitis C following a High Intensity Test and Treat (HITT) event at HMP Styal.

She was one of nine women who tested positive, all of whom were able to start treatment three days later.

Our Prison Peer Lead held a support clinic with all of the women. It was here where she met Lucy.

Lucy was from Skelmersdale. She began using drugs in her late teens, starting with amphetamines before moving on to heroin.

Having used IV drugs for eight years, Lucy said she had struggled to stay connected with the local drug services.

With only two weeks left of her sentence, we wanted to make sure that Lucy would be able to complete her treatment once she returned to Skelmersdale.

After talking Lucy through our Follow Me programme and the support The Hepatitis C Trust could offer her in the community, Lucy was pleased to stay in contact with us.

Since Lucy had tested positive, she knew it was really important that her partner get tested too. However, she confided with us that her partner would not attend any appointments at the local drug service for testing.

Our Prison Peer Lead made contact with our Community Coordinator for the Merseyside area, explaining the situation. Together, they arranged for the community team to visit Lucy’s home the day after she was released.

The community team completed a Dry Blood Spot Test (DBST) on Lucy’s partner and sent it off to the hospital for the results. The test came back positive and less than three weeks later he started

his own course of treatment.

Having built up a relationship with our Community Coordinator, Lucy helped two more of her friends get tested. One friend was also found to have hepatitis C and was supported onto treatment by our team.

The names in these stories have been changed

SEAN’S PEER JOURNEY

It is always challenging to get prison peers involved in our work at high security prisons.

But Sean was a passionate advocate for hepatitis C awareness after being diagnosed and cured of the virus himself. He successfully completed peer mentoring training in a one-to-one session.

His prison recently went paperless so we were unable to provide Sean with any literature to pass out and security measures mean that he is not able to host any group sessions on his wing.

To get round these challenges, we worked with the prison to create a podcast which could be accessed via laptops in people’s cells.

Sean was able to tell his story on the podcast and share his experiences of homelessness, substance use and the criminal justice system.

OUR 2023-24 PRIORITY

› To increase our reach across the criminal justice system and ensure that all people with hepatitis C within custodial settings have access to testing and treatment.

He described how he felt being diagnosed with hepatitis C whilst in a high security prison and how lonely and scared he felt until he started treatment. He reassured listeners that they could be cured by taking a simple course of tablets.

This story really resonated with listeners and encouraged people to get tested ahead of our HITT event.

Sean is someone who always thinks outside the box and is full of ideas about other ways we can raise awareness despite security restrictions. He has really contributed to the work of our prisons team.

The names in these stories have been changed

“ Having built up a relationship with our Community Coordinator, Lucy helped two more of her friends get tested.”

Achievements and Performance

TRAINING TO MAKE SURE NO ONE IS LEFT BEHIND

2022-23 TARGET

To increase our reach to ensure no one is left behind, while working with partners to gather strong data to support elimination

We are proud to be a peer-led organisation; with around a third of our staff starting their journey with us via our volunteer programme.

This year we also recognised the urgent need to ensure our team on the ground is equipped with knowledge of first aid in case of a medical emergency. Our volunteers and staff meet with people who use drugs every day and sadly, the risk of overdose remains high in this community.

Personal experience of hepatitis C or drug use gives our volunteers a unique understanding of the wider issues that affect many of the people we support. This common ground helps patients to engage with us and overcome barriers to starting treatment.

In response to this need, staff from our training team are now qualified first aid trainers and have started to roll out a Level 3 emergency first aid at work programme to all staff and volunteers.

Every volunteer receives comprehensive training including a three-day residential training course and induction, regular line management meetings and ongoing support, and access to a range of accredited training courses.

We have also updated our safeguarding training to help build our staff and volunteers’ confidence in recognising when a patient is at risk. We have also appointed regional safeguarding officers across the Community and Prison programmes to support with this.

Around 65% of people who have volunteered with us have moved on to paid employment either within the Trust or further afield.

45	external BBV professional
	training events
105	accreditations awarded to staf
	and volunteers
116	new peer volunteers received
	induction training

In recognition of all the hard work our volunteers do on behalf of the Trust, we organised two national volunteer away days. This involved coordinating over 100 volunteers to attend events in Brighton and Sheffield from all corners of the UK. The volunteers enjoyed overnight stays in hotels, an awards ceremony for qualifications obtained with the Trust, a quiz with prizes, sing a longs and other fun-filled activities.

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

S T O R Y O F I M P A C T

DAMIAN’S PEER STORY

My family was pretty dysfunctional when I was

I started volunteering for the Trust about a year ago. I quickly felt welcomed, supported and held by the team. They helped me through my induction training with Archie and Liz. The induction training was really good and made me realise that my past experience of drug use and hepatitis C could help others. I started to feel I had something to offer which improved my low self-worth and confidence.

growing up. My dad had issues with gambling and my mum with prescription drugs, hoarding and shopping. I ended up going into care.

When I was nine, I had my first taste of alcohol. I smoked weed at 17 and then the progression of my addiction happened really quickly.

Within two years I was using heroin. I first injected at 19, sharing the equipment with those present. I don’t know how long I had hepatitis C but I found out I had it in 2009 after being admitted to hospital with breathing problems. I had interferon, cleared the virus and stopped injecting drugs. I continued to use alcohol and weed.

The whole experience with the Trust has been amazing and I feel blessed for having the opportunity. When I was told I was ready to apply for a paid role it made me feel very emotional. I finally felt that I was contributing and had something to give and it was something I love doing. Working for the Trust has aligned with my recovery and given me a purpose. It has helped integrate me back into society. I feel very lucky to be part of the team.

When I went into recovery 19 months ago, it was suggested I give something back.

“ I started to feel I had something to offer which improved my low self-worth and confidence.”

DEB’S TRAINING STORY

Like many people, I always struggled in a

classroom as a child and was worried about putting myself back into a learning environment. From day one, the Trust reassured us that we would be supported through any sort of training we took up with them. So many people who work at the Trust have been through the volunteer programme and have gone on to gain employment. This filled me with a confidence I never had before – if they could do it so could I.

One of the early qualifications I took up was called

Supporting Individuals with Learning Disabilities Level 2. The Trust training team brought a group of us together for a two-day induction to the qualification. They went through what we needed to do to pass the course and we all spoke about previous barriers we faced in education and ways we could overcome them.

OUR 2023-24 PRIORITY

› To continue increasing our numbers of peer volunteers and supporting them through their development journey while ensuring opportunity.

Support from the Trust and the other volunteers over the two days helped me understand what was expected of me and improved my confidence. Knowing we had shared similar backgrounds in life and education meant we were able to motivate and support each other in a way that we’d never experienced in school.

After the induction, we continued to meet up with and speak to other volunteers in study groups. If one of us was stuck on something or beginning to lose motivation, someone else would be able to help. It was wonderful when we completed the qualification – I felt not only proud of myself but the others in the group too.

Now I’ve moved on to a Level 2 Diploma in Adult Care. This time I feel even more motivated and my self-belief continues to grow. Now I know I can do anything I put my mind to.

Achievements and Performance

SUPPORT FOR THE INFECTED BLOOD COMMUNITY

2022-23 TARGET

To represent and support those infected and affected by infected blood, and widen our resource within this support.

As well as emotional support, we offer guidance to people making applications for financial support from the UK blood support schemes, which can be a complicated process to navigate.

Our helpline has been running since 2004 and has received around 63,000 contacts. It remains an essential resource for many people who have or have had hepatitis C, with the number of inquiries continuing to grow every year.

This year, we broadened the services we offer by holding regular online support groups for members of the infected blood community. The groups have been a great success and offer people a place to connect and share their thoughts and feelings around the impact of the Infected Blood Inquiry.

It has been a challenge for our small but dedicated team to keep up with the volume of calls, particularly from those impacted by the infected blood scandal. Training other office staff to support taking calls during busy periods has been an important way to adapt.

The helpline offers practical and emotional support to people who often feel like they have no place left to turn.

We continued to attend the hearings of the Inquiry in person to provide emotional support to people who were taking part. This included people who had been recently diagnosed or who were attending the Inquiry on their own.

For those from the ‘whole blood’ community (who contracted hepatitis C after receiving a blood transfusion), there are no other designated support or information services they can access. Many report finding their GPs uninformed about hepatitis C and rarely see their specialists to discuss any ongoing concerns. Unfortunately for many, other health problems are more likely to develop as a result of having a long-term infection, so their journey does not end when hepatitis C treatment is completed. We have found that people from this community often return to our helpline over many months, years and even decades as a result.

	19	support group sessions held
		for people afected by infected
		blood
	5,007	contacts via the helpline
	23	hearings of the Infected Blood
		Inquiry attended

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

S T O R Y O F I M P A C T

ONLINE SUPPORT FOR THE INFECTED BLOOD COMMUNITY

The long-running Infected Blood Inquiry

Sir Robert Francis’ compensation framework, challenges faced by people who are a part of the England Infected Blood Support Scheme and the psychological impact of hepatitis C via infected blood.

continued to receive evidence over the course of 2022-23. Because of this, there was an increased need for emotional support for the community that had been impacted.

In addition to this, we continue to provide informal and friendly advice via the Contaminated Whole Blood UK Facebook group and its 550 members. Engaging with the community on social media has helped to build strong relationships and ensures that they have the most reliable and up to date information about the Inquiry.

In response, we began to schedule online support groups on a fortnightly basis. Groups are limited to 12 attendees so that everyone has the opportunity to share their thoughts and feelings. In all, 96 people whose lives had been impacted by the infected blood scandal attended the sessions over the year.

Once the group was established, it became clear that there were some subjects that people wanted to learn about or explore in more detail. We therefore decided to run occasional focus groups for the community centred around specific needs or interests. Topics in 2022 included the

“

The meetings are reassuring, keep you updated about the hearings, treatment, ongoing topics and you feel part of a group with other survivors and family members.”

HELPING PEOPLE ACCESS SUPPORT SCHEMES

**Delilah* had been signposted to us by the**

“

Infected Blood Inquiry team for guidance in making an application to one of the UK Blood Support Schemes.

We arranged for someone to visit Delilah’s home, get her on to treatment and get her cured of the virus.”

Since being diagnosed in 1991, Delilah had never spoken to anyone outside of her family about hepatitis C and was nervous about calling us. She felt reassured when our helpline staff said that they had their own experiences of the virus too.

Aside from the help we could practically offer her to ensure she would successfully access the UK Blood Support Scheme, we learnt that she had shunned all further medical care. She had declined the treatment that was available at the time of her diagnosis and disengaged from being further monitoring. Although Delilah was registered with a GP she told us that she had never been to see them.

We arranged for someone to visit her home, get her on to treatment and get her cured of the virus.

Delilah said: “Without the support and patience of The Hepatitis C Trust I would still be hiding away, the team gave me the confidence and help to do this, and I will always be grateful to them”.

The names in these stories have been changed

By the time she spoke to us she had been living with hepatitis C for 40 years. We were able to answer all her questions and talk to her about the new treatments that were available. Although she was interested, her fear of doctors, medical treatments and disclosing her infection to anyone was still a major stumbling block.

OUR 2023-24 PRIORITY

› To continue to represent and support those infected and affected by infected blood and widen our resource within this support.

SUPPORT GROUP PARTICIPANT

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

WORLD HEPATITIS DAY 2022 events held in partnership with services and charities 189 across the UK people engaged 4,019 people tested 1,741

Achievements and Performance

KEEPING HEPATITIS C ELIMINATION ON THE POLITICAL AGENDA

2022-23 TARGET

To ensure continued parliamentary support for the hepatitis C elimination programme and the elimination targets, and to increase focus on strong prevention policies and preparation for the maintenance phase of elimination.

Keeping hepatitis C elimination on the political agenda is one of our most important priorities. We work tirelessly to ensure that action is being taken at government level so that the UK achieves its elimination targets.

Hepatitis C Parliamentary Champions Miles Briggs and Rhoda Grant. We supported MSPs to table Written Questions highlighting areas of concern for meeting the 2024 elimination target.

In Wales, we organised a Senedd (Welsh Parliament) drop in event, where we engaged with Members of the Senedd (MSs), held meetings with MSs and provided briefings and Written Questions in support of parliamentary activity. This led to the Welsh Government setting out a new plan for getting on track for hepatitis C elimination by 2030.

In England, we celebrated the progress that has been made as part of the hepatitis C elimination deal and galvanised support from MPs and decision makers at a World Hepatitis Day parliamentary reception.

We also successfully conducted meetings and hosted constituency visits for MPs including with Steve Brine, Chair of the Health and Social Care Committee. We supported a range of parliamentary activity by providing briefings for debates, supporting MPs to table Written Questions and submitting responses to parliamentary consultations.

We continued to lend our support to campaigners seeking justice for the infected blood scandal by providing briefings to MPs for a debate in Parliament on the issue.

politicians engaged with at oneto-one meetings and events.

26 15 120

In Scotland, we met with cross-party Members of the Scottish Parliament (MSPs) including Scottish Labour Party Leader Anas Sarwar and long-term

Parliamentary Questions tabled on hepatitis C.

attendees at our World Hepatitis Day parliamentary reception.

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

S T O R Y O F I M P A C T

PARLIAMENTARY RECEPTION

For World Hepatitis Day, we organised and

hosted a parliamentary reception in Westminster. The event brought together 120 people, including Hepatitis C Trust staff, NHS workers, other partner organisations and parliamentarians. We celebrated all that has been achieved so far in tackling hepatitis C and motivated all involved to continue working towards the target of eliminating the virus in England by 2025.

We were delighted to be joined by a cross-party group of politicians for the event, including Maggie Throup, the then Health Minister with responsibility for hepatitis C. Other MPs in attendance included: Dan Carden, Peter Dowd, Paulette Hamilton, Kate Hollern, Rachel Hopkins,

Diana Johnson, Naz Shah and Jeff Smith as well as Baroness Randerson.

The reception was hosted by Elliot Colburn MP and featured speeches from representatives from the World Health Organization and NHS England, as well as The Hepatitis C Trust.

The event helped to ensure hepatitis C remains a focus for parliamentarians, helping them to understand the specific challenges we face on the ground when working in their constituencies. Many MPs who attended went on to highlight hepatitis C in the House of Commons, table Written Questions and raise awareness via social media.

“ We’ve made great progress in tackling hep C in recent years but more needs to be done.”

MAGGIE THROUP MP

OUR 2023-24 PRIORITY

› To ensure parliamentarians are aware of the importance of preparing for maintaining hepatitis C elimination once achieved, and that there is a strategy in place for the maintenance phase.

Achievements and Performance

KEEPING THE HEPATITIS C PROFESSIONAL COMMUNITY INFORMED AND CONNECTED

2022-23 TARGET

To support the hepatitis C professional community to achieve hepatitis C elimination across the UK by improving prevention, diagnosis and treatment, and to support a transition to new arrangements for hepatitis C services to ensure sustainable maintenance of elimination.

The vital role of HCV Action

elimination and for healthcare professionals to learn from each other.

To complement our patient-focused work, we also coordinate HCV Action, a network of more than 1,000 healthcare professionals with an interest in hepatitis C.

Our report, ‘Taking the initiative: how England is eliminating hepatitis C’, provided an overview of England’s hepatitis C elimination programme, documenting for the first time the various elimination initiatives that have helped England stay on track to achieve elimination by 2025.

HCV Action’s role as the voice of the hepatitis C professional community continued to strengthen in 2022-23. Our annual conference for hepatitis C professionals attracted its largest audience yet, with more than 100 attending in person and over 200 joining via live stream.

HCV Action’s ongoing core activity – including producing good practice case studies and monthly e-updates, gathering and distributing key resources, and providing updates via Twitter – help to ensure the hepatitis C professional community remains informed, inspired and connected throughout the year.

We also hosted three webinars for HCV Action members across the year, attracting larger audiences every time. These online sessions are a great way to keep momentum up as we near

314	people attended the annual
	HCV Action conference in
	person and online.
313	attendees across three HCV
	Action webinars.
722	YouTube views of 2022-23 HCV
	Action webinars and event
	recordings.

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

S T O R Y O F I M P A C T

TAKING THE INITIATIVE

In Spring 2023, we published our report,

The report outlines:

‘Taking the initiative: how England is eliminating hepatitis C’. The report explores the development of England’s hepatitis C elimination programme since 2019, providing an overview of the main elimination initiatives to find and treat those living with hepatitis C.

how the elimination programme was developed
how the elimination initiatives have evolved
what lessons have been learned for combatting hepatitis C and other health challenges
the next steps in the final period of the deal as it comes to an end in March 2024.

To gather the information required for the report, we undertook desk research and conducted interviews with key stakeholders, including representatives from NHS England, The Hepatitis C Trust and the pharmaceutical industry.

The report highlights that a new arrangement will be required to continue the work of at least some of these initiatives and keep up momentum towards the goal of elimination by 2025, and to ensure elimination is maintained in the long term.

Following publication, the report’s findings and recommendations were raised with government ministers in Written Parliamentary Questions by supportive parliamentarians.

“ A very important piece of work with a robust assessment of what we have achieved.”

NHS ENGLAND HEPATITIS C ELIMINATION PROGRAMME TEAM

HCV ACTION ANNUAL CONFERENCE

“

This year, we were delighted to host the annual

HCV Action conference in person for the first time since 2019. The event programme explored emerging areas of interest and best practice, including planning for maintaining elimination, network-tracing approaches to treatment and hepatitis C testing in emergency departments and probation services.

All the sessions were invaluable in helping me to understand the pieces of the jigsaw and how they fit together.”

To maximise the accessibility of the event, we also arranged for the event to be live streamed. The conference was attended by more than 100 people in person and the live stream attracted 214 views. 22 of the 23 hepatitis C Operational Delivery Networks (ODNs) had representation at the event.

CONFERENCE ATTENDEE

The return to an in person format helped to increase the interactivity of the day and we were pleased to hear from delegates that new connections established were followed up afterwards. The vast majority of respondents to our feedback survey said that the conference made them feel more informed about the elimination programme and about how hepatitis C services will transition in the coming years. Attendees also expressed how useful the conference was in learning from examples of best practice elsewhere that can be replicated in their own ODNs.

OUR 2023-24 PRIORITY

› To support the hepatitis C professional community by providing a forum for the discussion of developments, challenges and opportunities in the elimination programme.

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

ART ON A POSTCARD

Art on a Postcard (AOAP) fundraises for The Hepatitis C Trust via charity auctions and the sale of merchandise on their online shop.

Established in 2014, AOAP was intended to be a one-off secret postcard auction, but it went so well it spawned a small industry.

Every AOAP auction features an impressive line-up of postcard-sized masterpieces which include works by Britain’s most renowned artists.

MINI AUCTIONS

AOAP held several mini auctions to fundraise for our work in 2022. These were great opportunities for AOAP to engage with and feature the work of up-and-coming artists. Held at various locations across London, AOAP was able to raise £23,000 from these events.

AUCTION FOR UKRAINE

In April 2022, war broke out in Ukraine. We decided that it would be appropriate to ask AOAP to donate the funds raised at an auction curated by India Rose James to support the work of the charity Choose Love, who were helping to support Ukrainian refugees. The auction raised £22,000.

SUMMER AUCTION 2022

Teaming up with The Other Art Fair, AOAP raised £45,000 at this auction. The sale featured works by National Portrait Gallery BP Portrait Award-

winner Ishbel Myerscough and Marina Abramović,

alongside emerging artists such as Jade Montserrat, Tosin Kalejaye and Ruairi Fallon.

WINTER AUCTION 2022

The annual winter auction was AOAP’s most successful event to date. Partnering with Dreweatts, almost 600 pieces of incredible artwork were donated to the online auction. Contributors included Grayson Perry CBE RA, Clayton Schiff, Caroline Wong and Gavin Turk. A private viewing of the artwork was also held in London ahead of the sale. The auction raised an incredible £96,000.

INTERNATIONAL WOMEN’S DAY AUCTION 2023

For its International Women’s Day Auction, AOAP invited seven female curators to organise a show featuring 25 women artists. The auction raised £41,000 with support from The Auction Collective and Fitzrovia Gallery who hosted the Private View.

ONLINE SHOP

The range on the AOAP website continued to grow, with art fans being able to order Christmas and greetings cards, prints, frames and box sets featuring popular designs from previous auctions on the website.

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

GOVERNANCE AND MANAGEMENT

OUR TRUSTEES

LEGAL ENTITY

The Trust was incorporated in England and Wales on 10 March 2004 (registration number 05069924) and gained charitable status on 10 June 2004 (charity number 1104279). On 1 September 2004 all the charitable activities, assets and liabilities from the original unincorporated charity, The Hepatitis C Trust (charity number 1083097), were transferred to this incorporated charity. On 1 October 2008 the charity registered in Scotland (charity number SCO39914). The current charity is governed by its Memorandum and Articles of Association.

CHARITABLE OBJECTS

The objects of the Trust, as set out in the Memorandum and Articles of Association are:

The relief of persons suff ering from hepatitis C and the provision of support to such persons and their families;
The advancement of education concerning hepatitis C; and
Research into all aspects of hepatitis C including (but not limited to) the causes, detection, transmission, prevention and treatment of hepatitis C and the publication and dissemination of the useful results of all such research.

(those who served during the year and/or were responsible for the annual report)

The Hon David Macmillan (Chair)

Mr Simon Lincoln (Treasurer)

Sir Adrian Baillie

Dr M F Bassendine

Mr Peter Holt

Mr Edward Mead

Mr Charles Walsh

Mr John Jolly

OUR PATRONS

Ms Emilia Fox

Ms Sadie Frost Boy George Mr Andrew Loog Oldham The Lord Mancroft

Mr Alan McGee

Ms Justine Roddick

Mr Robbie Williams

RECRUITMENT AND APPOINTMENT OF TRUSTEES

The charity’s Trustees are also the company directors for the purposes of company law. Subsequent Trustees may be appointed by ordinary resolution. When vacancies occur new Trustees are recruited through a variety of means including advertising. The Trust wishes to have patients as a majority of its Board, which increases the challenge of finding suitable and willing Trustees. Potential Trustees have an initial meeting with the Chief Executive who explains the Trust’s philosophy and how it works in practice. They are then asked to attend a Board meeting to get a better understanding. Newly appointed Trustees are sent briefing information about The Trust and their role as a trustee. They are then asked to spend a day at the Trust’s London offices, meeting the staff and learning more about each project and in particular financial oversight.

KEY MANAGEMENT PERSONNEL

The Trustees have determined that the Chief Executive and the Senior Directors, together with the Trustees themselves, are the key management personnel. The Trustees are not remunerated and the pay of the Chief Executive and the Senior Directors has been set according to bands suggested by an independent consultant and by benchmarking against market rates.

RISK ASSESSMENT

The Trustees have prepared a risk assessment, examining the major risks which the charity faces and have set out the necessary steps that need to be taken to lessen any risks. This register is updated on a regular basis. The key risks and the actions to be taken to mitigate them in the latest risk assessment are set out in the table below.

CHIEF EXECUTIVE

Rachel Halford

The Hepatitis C Trust Annual Report 2023 | Achievements and Performance

FINANCIAL REVIEW

FUNDING

Following the successful delivery of our ongoing peer programmes, we received further investment under the NHS elimination initiative this year. As such our income has, once more, continued to significantly increase, allowing us to maintain a secure financial position for the Trust. At £4,988,926 our income has significantly increased from that of the previous year £3,632,826, while our expenditure at £4,411,630 increased by £1,374,365. This increase in expenditure is in line with additional costs incurred through the implementation and running of our extended peer programme service delivery.

With the continued successful delivery of our peer programmes, we remain confident in our financial position. In relation to our raising funds, please see our costs in the financial statements at the back of the report, mainly in regard to income generation from Art on a Postcard (see page 22). We do not engage external professional fundraisers or commercial participators to carry out our fundraising activities and we do not engage in face-to-face or telephone fundraising. All our approaches to fundraising take account of the Code of Fundraising Practice issued by the Fundraising Regulator. We have received no complaints about our fundraising activities either during the financial year or subsequently.

RESERVE POLICY

The policy of the Trustees is to hold a reserve of three months’ costs, amounting to £1,470,543. Our total unrestricted reserves for this year are £1,190,834, this includes £307,424 which has been designated for future redundancy costs in line with the completion of NHS England’s funded elimination programme. Alongside this are our current restricted reserves of £678,792 to fund activities in the year 31 March 2023.

The Trustees are committed to raising core reserves through our fundraising strategy involving: broadening our base of possible trust funders by demonstrating that addressing hepatitis C has broader social benefits, not just positive health outcomes; engaging with corporate donors; expanding Art on a Postcard; moving our focus towards longer term statutory funding.

STATEMENT OF TRUSTEES’ RESPONSIBILITIES

The Trustees (who are also directors of The Hepatitis C Trust for the purposes of company law) are responsible for preparing The Trustees’ Report and the Financial Statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. In so far as the Trustees are aware:

•There is no relevant audit information of which the charitable company’s auditor is unaware; and

Company law requires Trustees to prepare financial statements for each financial year which give a true and fair view of the state of the affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to:

the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.

AUDITORS

Azets Audit Services (formerly Wilkins Kennedy Audit Services) have indicated their willingness to continue in office. A resolution proposing their re-appointment will be submitted at the Annual General Meeting.

select suitable accounting policies and then apply them consistently;
observe the methods and principles in the Charities SORP 2015 (FRS 102);

SMALL COMPANY RULES

make judgements and estimates that are reasonable and prudent;

These accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies and with the Statement of Recommended Practice, Accounting and Reporting by Charities (SORP FRS 102) issued in January 2015. This report was approved by the Board of Trustees and signed on its behalf by:

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for

The Hon David Macmillan

22[nd] December 2023

The Hepatitis C Trust Annual Report 2023 | Independent Auditor’s Report

F I N A N C I A L S T A T E M E N T

FINANCIAL STATEMENTS FOR THE YEAR ENDED

31 MARCH 2023

Registered in England and Wales Charity Number: 1104279

Registered in Scotland Charity Number: SCO39914

Registered Company Number: 5069924

INDEPENDENT AUDITORS’ REPORT TO THE MEMBERS OF THE HEPATITIS C TRUST

OPINION

We have audited the financial statements of The Hepatitis C Trust (the ‘charitable company’) for the year ended 31 March 2023 which comprise the Statement of Financial Activities, the Balance Sheet, the Cash Flow Statement and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements: give a true and fair view of the state of the charitable company’s affairs as at 31 March 2023, and of its incoming resources and application of resources, including its income and expenditure, for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

BASIS FOR OPINION

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

CONCLUSIONS RELATING TO GOING CONCERN

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

OTHER INFORMATION

The other information comprises the information included in the trustees annual report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

The Hepatitis C Trust Annual Report 2023 | Independent Auditor’s Report

INDEPENDENT AUDITORS’ REPORT TO THE MEMBERS OF THE HEPATITIS C TRUST

OPINIONS ON OTHER MATTERS PRESCRIBED BY THE COMPANIES ACT 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the trustees’ report (incorporating the directors’ report) for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the directors’ report has been prepared in accordance with applicable legal requirements.

MATTERS ON WHICH WE ARE REQUIRED TO REPORT BY EXCEPTION

In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors’ report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors’ remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit; or
the trustees were not entitled to prepare the financial statements in accordance with the small companies’ regime and take advantage of the small companies’ exemptions in preparing the directors’ report and from the requirement to prepare a strategic report.

RESPONSIBILITIES OF TRUSTEES

As explained more fully in the trustees’ responsibilities statement, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

AUDITOR’S RESPONSIBILITIES FOR THE AUDIT OF THE FINANCIAL STATEMENTS

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.

The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud is detailed below:

Enquiry of management and those charged with governance around actual and potential litigation and claims as well as actual, suspected and alleged fraud;
Reviewing minutes of meetings of those charged with governance;
Assessing the extent of compliance with the laws and regulations considered to have a direct material effect on the financial statements or the operations of the company through enquiry and inspection;
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
Performing audit work over the risk of management bias and override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for indicators of potential bias.

Due to the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities is available on the Financial Reporting Council’s

website at: https://www.frc.org.uk/Our-Work/ Audit/Audit-and-assurance/Standards-andguidance/Standards-and-guidance-for-auditors/ Auditors-responsibilities-for-audit/Description-ofauditors-responsibilities-for-audit.aspx.

This description forms part of our auditor’s report.

USE OF OUR REPORT

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Lorraine Curtis ACA BFP FCCA

(Senior Statutory Auditor)

For and on behalf of Nordens Audit Limited

Statutory Auditor The Retreat 406 Roding Lane South Woodford Green Essex IG8 8EY

22[nd] December 2023

Nordens Audit Limited is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006.

The Hepatitis C Trust Statement of Financial Activities

Incorporating an Income and Expenditure Account For the year ended 31 March 2023

Unrestricted Note Funds £ Income from: Donations 2 317,476 Investments 3 15,605 Charitable activities 4 3,201,983 Total 3,535,063 Expenditure on: Raising funds 5 218,657 Charitable activities 6 2,528,497 Total 2,747,154 Net income for the year before transfers 787,910 Transfers 12 206,215 Net income 994,124 Fund balances at 1 April 2022 12 1,190,834 Fund balances at 31 March 2023 12 2,184,958	Restricted Funds £ - - 3,773,727 3,773,727 - 3,780,099 3,780,099 (6,732) (206,215) (212,587) 678,792 466,205	Total 2023 £ 317,476 15,605 6,975,709 7,308,790 218,657 6,308,596 6,527,252 781,538 - 781,538 1,869,626 2,651,164	Total 2022 £ 210,443 336 4,778,147 4,988,926 172,834 4,238,796 4,411,630 577,296 - 577,296 1,292,330 1,869,626

The Hepatitis C Trust Balance Sheet as at 31 March 2023

Note Current Assets Debtors 10 Cash at bank and in hand Creditors: Amounts falling due within one year 11 Net Current Assets Total Net Assets Funds Unrestricted funds 12 Designated funds 12 Restricted funds 12	2023 £ 2022 £ 1,783,098 720,881 2,538,587 2,313,341 4,321,685 3,034,222 (1,670,521) (1,164,595) 2,651,164 1,869,626 2,651,164 1,869,626 1,624,026 883,410 560,932 307,424 466,206 678,792 2,651,164 1,869,626

The accounts have been prepared in accordance with FRS 102.

These financial statements have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Trustees and authorised for issue on 22 December 2023 and signed on their behalf by:

………………………………………

Hon David Macmillan

Registered Company Number: 5069924

The notes on pages 48 to 61 form part of the financial statements.

All gains and losses arising in the year have been included in the Statement of Financial Activities and arise from continuing operations

The notes on pages 48 to 61 form part of the financial statements.

The Hepatitis C Trust Statement of Cash Flows For the year ended 31 March 2023

Notes 2023 £ Cash generated from operating activities: Net cash provided by operating activities see below 209,641 Cash flows from investing activities: Interest income 3 15,605 Net cash provided by investing and operating activities 225,246 Change in cash and cash equivalents in the reporting period Cash and cash equivalents at the beginning of the reporting period 2,313,341 Cash and cash equivalents at the end of the reporting period 2,538,587 Reconciliation of net expenditure to net cash flow from operating activities 2023 ., £ Net expenditure (as per the statement of financial activities) SOFA 781,538 Adjustments for: Investment income 3 (15,605) Increase in debtors 10 (1,062,217) Increase in creditors 11 505,925 Net cash provided by operating activities 209,641 Analysis of cash and cash equivalents 2023 £ Cash in hand 2,538,587 Total cash and cash equivalents 2,538,587	2022 £ 697,932 336
	698,268
	1,615,073
	2,313,341
	2022 £ 577,296 (336) (145,498) 266,470
	697,932
	2022 £ 2,313,341
	2,313,341

1 The Hepatitis C Trust Notes to the Financial Statements For the year ended 31 March 2023

Accounting Policies

Basis of Preparation

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), the Charities Act 2021, the Companies Act 2006 and UK Generally Accepted Accounting Practice.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound.

The financial statements are prepared under the historical cost concept.

The principle accounting policies adopted in the preparation of the financial statements are set out below.

Going Concern Basis

The trustees have assessed whether the use of the going concern basis is appropriate and have considered possible events or conditions that might cast significant doubt on the ability of the charity to continue as a going concern. The trustees have made this assessment for a period of at least one year from the date of approval of the financial statements. In particular the trustees have considered the charity’s forecasts and projections. After making enquiries the trustees have concluded that there is a reasonable expectation that the charity has sufficient resources to continue in operational existence for the foreseeable future. The charity therefore continues to adopt the going concern basis in preparing its financial statements.

Income

Income is recognised in the period to which it relates, when the criteria of entitlement, measurable and probable receipt are met.

Deferred income is income which is received in respect of a future accounting period and is deferred to that period.

Gifts in kind are valued and brought in as income and the appropriate resources expended, when the items are used/distributed. The values attributable to gifts in kind are an estimate of the gross value to the organisation, usually the market cost. Where this intangible income relates to project activities it is included as an activity in furtherance of the charity's objects.

Expenditure

Direct charitable expenditure comprises all expenditure relating to the activities carried out to achieve the objectives.

Governance costs include those costs incurred in the governance of the charity and are primarily associated with constitutional compliance and statutory requirements.

Expenditure is allocated directly to the expenditure headings as far as practically possible to reflect the activities of the charity. Support costs have been allocated to the activities based on employee time spent on that activity.

The Hepatitis C Trust Notes to the Financial Statements For the year ended 31 March 2023

1. Accounting Policies (continued)

Expenditure is included in the Statement of Financial Activities on an accruals basis, inclusive of any VAT which cannot be recovered. Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

Fund accounting

Restricted funds are subject to restrictions imposed by the donor. These are accounted for separately from unrestricted funds and full details are given in note 12.

Unrestricted funds are those which are not subject to restrictions, and any surpluses may be applied in furtherance of any of the organisation's objectives.

Cash and Cash Equivalents

Cash and cash equivalents include cash at banks and in hand and short-term deposits with a maturity date of three months or less.

Debtors and creditors

Debtors and creditors receivable or payable within one year of the reporting date are carried at their transaction price. Debtors and creditors that are receivable or payable in more than one year and not subject to a market rate of interest are measured at the present value of the expected future receipts or payment discounted at a market rate of interest.

Pension

The charity operates a defined contribution stakeholder pension scheme. The assets of the scheme are held separately from the charity.

Critical accounting estimates and areas of judgement

The annual depreciation charge for property, plant and equipment is sensitive to change in useful economic life and residual values of assets. These are reassessed annually.

In the view of the trustees in applying the accounting policies adopted, no other judgements were required that have a significant effect on the amounts recognised in the financial statements nor do any estimates or assumptions made carry a significant risk of material adjustment in the next financial year.

2. Donations

Year to 31 March 2023

Donations Art on a Postcard

Year to 31 March 2022

Donations Art on a Postcard

3. Investment Income

Year to 31 March 2023 Bank interest Year to 31 March 2022 Bank interest

The Hepatitis C Trust Notes to the Financial Statements For the year ended 31 March 2023

Unrestricted Funds 2023 £ 17,665 299,811 317,476 Unrestricted Funds 2022 £ 6,010 204,433 210,443 Unrestricted Funds 2023 £ 15,605 15,605 Unrestricted Funds 2022 £ 336 336			Restricted funds 2023 £ - - - Restricted funds 2022 £ - - - Restricted funds 2023 £ - - Restricted funds 2022 £ - -			Total 2023 £ 17,665 299,811
						317,476
						Total 2022 £ 6,010 261,772
						210,443
						Total 2023 £ 15,605 15,605 Total 2022 £ 336 336

4. Income for Charitable Activities

Income for Charitable Activities
Year to 31 March 2023 Grants 4a Year to 31 March 2022 Grants 4a	Unrestricted Funds 2023 £ 3,201,983 3,201,983 Unrestricted Funds 2022 £ 1,641,381 1,641,381	Restricted funds 2023 £ 3,773,727 3,773,727 Restricted funds 2022 £ 3,136,767 3,136,767	Total 2023 £ 6,975,709
			6,975,709
			Total 2022 £ 4,778,147
			4,778,147

The Hepatitis C Trust Notes to the Financial Statements For the year ended 31 March 2023

4a Grants

4a Grants (Continued)

Year to 31 March 2023 AbbVie Ltd AbbVie Ltd (HCV Action) Barts Health NHS Trust Betsi Cadwaladr University Local Health Board Birmingham and Solihull Mental Health NHS Foundation Bournemouth Christchurch and Poole Council Brighton and Sussex University Hospitals NHS Foundation Trust Cambridge University Hospitals NHS Foundation Trust Cheshire and Merseyside ODN East Lancashire Hospitals NHS Trust Gilead - Scotland Peer Project Gilead - HCV Action & Parliamentary Work Gilead HITT Hull University Teaching Hospitals Kings College Hospital Leeds Teaching Hospitals NHS Trust Mary Kinross Charitable Trust Merseycare MSD MSD – HCV Action NHS England NHS England and NHS Improvement – East Midlands (H&J) NHS Manchester NHS Thames Valley NHS Forth Valley NHS West London – Imperial College NHS Trust Nottingham University Hospitals NHS Trust Other Oxleas NHS Foundation Trust Practice Plus Group Health and Rehabilitation Services Limited Public Health Wales NHS Trust Royal Surrey NHS Foundation Trust Sheffield Teaching Hospitals NHS Foundation Trust (Peer Education) Sheffield Teaching Hospitals NHS Foundation Trust (T&V) South Tees Hospitals NHS Foundation Spectrum St George's University Hospitals NHS The Newcastle upon Tyne Hospitals NHS Foundation Trust University College London University Hospital Southampton NHS Foundation Trust University Hospitals Birmingham NHS Foundation Trust University Hospitals Bristol & Weston NHS Foundation Trust University Hospitals of Leicester NHS Trust University Hospitals Plymouth NHS Trust	Unrestricted Funds 2023 £ - - 127,295 - - - 134,947 161,206 - 156,011 - - - 201,141 98,000 113,399 - 37,500 - - - - 66,692 176,747 - 160,569 230,026 38,695 - - - 110,000 136,795 - 9,661 - 119,715 112,624 - 142,569 309,979 163,468 241,299 153,647 3,201,983	Restricted funds 2023 £ 675,000 25,000 - 98,276 25,361 2,000 - - 39,759 - 47,755 42,500 130,000 - - 39 38,000 - 944,715 75,000 390,521 105,009 - - 5,000 - 34,786 24,077 50,000 301,557 2,940 - - 306,440 - 259,992 - - 150,000 - - - - - 3,773,727	Total 2023 £ 675,000 25,000 127,295 98,276 25,361 2,000 134,947 161,206 39,759 156,011 47,755 42,500 130,000 201,141 98,000 113,438 38,000 37,500 944,715 75,000 390,521 105,009 66,692 176,747 5,000 160,569 264,812 62,772 50,000 301,557 2,940 110,000 136,795 306,440 9,661 259,992 119,715 112,624 150,000 142,569 309,979 163,468 241,299 153,647
			6,975,709

Year to 31 March 2022 AbbVie Ltd AbbVie Ltd (HCV Action) Barts Health NHS Trust Birmingham and Solihull Mental Health NHS Foundation Bournemouth Christchurch and Poole Council Brighton and Sussex University Hospitals NHS Foundation Trust Cambridge University Hospitals NHS Foundation Trust Coventry City Council Crossroads Care South East London East Lancashire Hospitals NHS Trust Falkirk Council Gilead - Scotland Peer Project Gilead - HCV Action & Parliamentary Work Gilead HITT Hull University Teaching Hospitals Kings College Hospital Leeds Teaching Hospitals NHS Trust MSD NHS England and NHS Improvement – East Midlands (H&J) NHS Thames Valley NHS Forth Valley NHS West London NHS Tayside Newcastle Track & Trace Nottingham University Hospitals NHS Trust Other Oxleas NHS Foundation Trust Pilgrim Trust Practice Plus Group Health and Rehabilitation Services Limited Public Health Wales NHS Trust Royal Surrey NHS Foundation Trust Royal Surrey NHS Foundation Trust (HITT) Sheffield Teaching Hospitals NHS Foundation Trust (Peer Programme) Sheffield Teaching Hospitals NHS Foundation Trust(Training and Volunteers) St George's University Hospitals NHS The National Health Service Commissioning Board (NHS England) The Newcastle upon Tyne Hospitals NHS Foundation Trust University Hospital Southampton NHS Foundation Trust University Hospitals Birmingham NHS Foundation Trust University Hospitals Bristol & Weston NHS Foundation Trust University Hospitals of Leicester NHS Trust University Hospitals Plymouth NHS Trust	Unrestricted Funds 2022 £ - - 80,000 - - 85,000 76,142 15,000 - 80,000 - - - - 40,000 80,000 78,867 - - 70,000 - 79,431 - 9,000 103,569 4,834 - - - 500 83,000 - 60,000 - 78,429 - 8,873 59,431 280,000 66,227 121,077 82,000 1,641,380	Restricted funds 2022 £ 674,346 55,040 - 14,484 2,000 - 366 - 5,760 - 5,000 4,996 52,500 130,000 - 24,263 - 893,936 140,012 - 20,000 - 3,503 - 2,691 546 50,000 15,000 730,882 150,000 546 29,383 - 75,000 - 56,513 - - - - - - 3,136,767	Total 2022 £ 674,346 55,040 80,000 14,484 2,000 85,000 76,508 15,000 5,760 80,000 5,000 4,996 52,500 130,000 40,000 104,263 78,867 893,936 140,012 70,000 20,000 79,431 3,503 9,000 106,260 5,380 50,000 15,000 730,882 150,500 83,546 29,383 60,000 75,000 78,429 56,513 8,873 59,431 280,000 66,227 121,077 82,000
			4,778,147

The Hepatitis C Trust Notes to the Financial Statements For the year ended 31 March 2023

7. Support Costs

5. Cost of Raising Funds

5. Cost of Raising Funds
Year to 31 March 2023 Staff Costs Direct Costs Year to 31 March 2022 Staff Costs Direct Costs	Unrestricted Funds 2023 £ 86,477 132,179 218,657 Unrestricted Funds 2022 £ 44,676 128,158 172,834	Restricted funds 2023 £ - - - Restricted funds 2022 £ - - -	Total 2023 £ 86,477 132,179
			218,657
			Total 2022 £ 44,676 128,158
			172,834

Staff costs Staff training Staff support costs Rent, rates, light and heat Travel and subsistence Insurance Office move Office supplies and maintenance Telephone Computer Costs Sundry costs Legal and professional costs Audit and accountancy Bank charges	Total 2023 £ 2,028 17,316 5,766 128,865 10,123 23,080 24,376 29,023 31,828 9,109 483 49,162 22,500 373 354,032	Total 2022 £ 22,383 - - 57,839 - 3,353 - 10,903 6,464 1,227 778 192 17,580 360
		123,559

All support costs were proportionally allocated to funders according to operational delivery in the year to 31 March 2023.

6. Analysis of Charitable Expenditure by type

Year to 31 March 2023 Advocacy and Drug Services HCV Action and Parliamentary Work Helpline National Volunteer & Trainer NHS Health & Justice Prison Peers Scotland Peer Project Women's Prisons World Hepatitis Day Year to 31 March 2022 Advocacy and Drug Services HCV Action and Parliamentary Work Helpline National Volunteer & Trainer NHS Health & Justice Prison Peers Scotland Peer Project Women's Prisons World Hepatitis Day	Staff Cost 2023 £ 3,225,289 - 16,586 82,212 977,302 32,795 101,898 - 4,436,083 Staff Cost 2022 £ 2,266,691 - 7,964 70,537 698,954 48,242 48,489 - 3,140,877	Direct Cost 2023 £ 899,694 131,884 2,698 89,867 347,192 12,373 30,826 3,947 1,518,481 Direct Cost 2022 £ 565,409 102,233 1,491 70,441 190,879 19,578 26,682 63 976,776	Support Cost 2023 £ - - - - - - - - - Support Cost 2022 £ 92,009 - - 1,297 27,837 - - - 121,143	Total 2023 £ 4,124,982 131,884 19,825 172,079 1,324,494 45,168 132,724 3,947
				5,954,564
				Total 2022 £ 2,924,109 102,233 9,455 142,275 917,670 67,820 75,171 63
				4,238,796

8. Staff Costs

Wages and salaries Social Security costs Pension costs Average number of employees during the year Average number of volunteers during the year One employee was paid in the range £60,000 to £69,999 in the year (2022: one).	2023 £ 3,989,050 410,771 125,638 4,525,459 Number 124 150	2022 £ 2,815,087 288,289 82,177
		3,185,553
		Number 94
		134

Key management personnel include the Trustees, Chief Executive (and senior management reporting directly to the Chief Executive). The total employee benefits, including pension costs and employers national insurance contributions of the charity's key management personnel were £293,302 (2022: £282,125). Four employees (2022: four) were considered to be key management personnel during the year.

9. Trustees and related parties

No remuneration was paid to any trustee for services as a trustee and no expenses were reimbursed.

Trustees participated in the Art on a Post Card auction on an arms-length basis.

The Hepatitis C Trust Notes to the Financial Statements For the year ended 31 March 2023

10. Debtors

Trade debtors Other debtors Prepayments	2023 £ 1,758,326 24,772 - 1,783,098	2022 £ 714,615 2,933 3,333 720,881

11. Creditors: Amounts falling due within one year

Trade creditors Tax and social security costs Sundry creditors Income received in advance Accruals	2023 £ 5,614 112,038 24,185 1,454,235 74,449 1,1670,521	2022 £ 28,793 80,121 5,347 1,002,264 48,070 1,164,595

The Hepatitis C Trust Notes to the Financial Statements For the year ended 31 March 2023

12. Statement of Funds (Continued)

. Statement of Funds (Continued)
Funds at 31 March 2021 £ Income £ Unrestricted funds 468,076 1,852,159 Designated fund - - 468,076 1,852,159 Restricted funds Advocacy and Drug Services 455,071 1,747,142 HCV Action & Parliamentary Work 37,046 107,540 National Volunteer & Training 74,990 80,760 NHS Health & Justice Prison Peers 247,636 1,095,614 Scotland Peer Project - 33,499 Women's Prisons 9,511 72,212 824,254 3,136,767 1,292,330 4,988,926	Expenditure £ Transfer of funds £ (1,297,903) (138,922) - 307,424 (1,297,903) 168,502 (1,808,558) (60,969) (102,233) - (142,275) - (917,670) (141,854) (67,820) 34,321 (75,171) - (3,113,727) (168,502) (4,411,630) -	Funds at 31 March 2022 £ 883,410 307,474
		1,190,834
		332,686 42,353 13,475 283,726 - 6,552
		678,792
		1,869,626

Income received in advance is funding for project work to be completed in the year 2023-24

12. Statement of Funds

Funds at 31 March 2022 £ Unrestricted funds 883,410 Designated fund 307,424 1,190,834 Restricted funds Advocacy and Drug Services 332,686 HCV Action & Parliamentary Work 42,353 National Volunteer & Training 13,475 NHS Health & Justice Prison Peers 283,726 Scotland Peer Project - Women's Prisons 6,552 678,792 1,869,626	Income £ 3,535,063 - 3,535,063 1,775,458 142,500 306,440 1,373,804 52,755 122,771 3,773,728 7,308,791	Expenditure £ (2,747,154) - (2,747,154) (1,973,749) (131,884) (172,079) (1,324,494) (45,169) (132,724) (3,780,099) (6,527,253)	Transfer of funds £ (47,293) 253,508 206,215 (47,700) - - (161,916) - 3,401 (206,215) -	Funds at 31 March 2023 £ 1,624,026 560,932
				2,184,958
				86,695 52,969 147,836 171,120 7,586 -
				466,206
				2,651,164

Designated Fund

The Trustees have agreed to designate funds for future redundancies in line with the completion of NHS England’s elimination programme

A transfer of £209,616 (2022: £202,823) was made from the restricted fund to the unrestricted funds to cover budgeted core spending provided for within the agreed budget.

A transfer of £3,401 (2022: £34,321) was made from unrestricted funds to restricted funds for the overspend on a restricted project that will not be reimbursed next financial year.

The Hepatitis C Trust Notes to the Financial Statements For the year ended 31 March 2023

13. nalysis of Net A ssets b etw een Funds

12. Statement of Funds (continued)

Restricted Funds

The nature and purpose of each of the funds is as follows:

dv ocacy and Drug Serv ices: includes peer-to�peer education and awareness programmes, delivering key messages about hepatitis C prevention, diagnosis, treatment and care to people attending community drug services, hostels and homeless shelter; this includes a bespoke South Asian peer programme. Staff training is carried out within all the programmes and is delivered to those staff working in services with people who are at a high risk of hepatitis C. We also have a mobile outreach programme which provides testing and raises awareness, especially amongst high prevalence communities and populations that are difficult to reach, such as the homeless

HCV A ction : a very useful vehicle for collecting and disseminating best practice in hepatitis C care and treatment, and for supporting Hepatitis C as the patient voice.

ear to 31 March 2023 Current assets Current liabilities ear to 31 March 2022 Current assets Current liabilities	Unrestricted Funds 2023 £ 2,048,006 (1,164,596) 883,410 Unrestricted Funds 2022 £ 2,048,006 (1,164,596) 883,410	Designated Funds 2023 £ 307,424 - 30 ,424 Designated Funds 2022 £ 307,424 - 30 ,424	Restricted Funds 2023 £ 678,792 - 6 6, 92 Restricted Funds 2022 £ 678,792 - 6 6, 92	Total 2023 £ 3,034,222 (1,164,596)
				1,869,626
				Total 2022 £ 3,034,222 (1,164,596) 1,869,626

National V olunteer and Training Serv ice:

The National team operate through two strands:

The delivery and oversight of core mandatory training and development of our staff including induction. Hepatitis C training to professionals and other service providers.
The delivery of The Hepatitis C Trust volunteering programme which includes supporting our volunteers across different areas of our work and ensuring that all are provided with opportunity to access training and development to both support them in their roles and further their employment opportunities.

NHS Health and Justice Prison Peers: The Hepatitis C Trust engages in peer-to-peer and awareness raising activities across UK prisons in order to: 1) Provide information about hepatitis C to those at risk an who are often hard to engage 2) Encourage and support people in prisons to get tested and to access treatment and care 3) Train people in prison to become Hepatitis C peers.

14. perating L ease Commitments

perating lease which expire: ess than 1 year Within 2-5 years	E uipment 2023 £ 2022 £ - - 3,096 3,096 9,288 12,384	and and uildings 2023 £ 2022 £ - 14,104 91,250 - 91,2 0 14,104	and and uildings 2023 £ 2022 £ - 14,104 91,250 - 91,2 0 14,104
			14,104

Scotland Peer Project: Peer-to-peer awareness and education project that provides key messages about hepatitis C prevention, diagnosis treatment and care to people attending recovery cafés, homeless hostels,shelters as well as people in prison. Our Voices group brings together people affected by hepatitis C,building their knowledge and awareness and supporting them in having their voices heard.

Women’s Prisons: Women specific hepatitis C peer programme working across the female prison estate educating, raising awareness, changing the conversation, reducing stigma and supporting women to get tested and treated.

THANK YOU

We would like to take this opportunity to thank our funders, from individual donors to large statutory and trust funders, with who we would not be able to achieve the work we have reported on this year. We greatly appreciate their commitment to our cause and the resources they provide in order for us to reach our goals.

We would like, in particular, to thank:

AbbVie Ltd Barts Health NHS Trust Birmingham and Solihull Mental Health NHS Foundation Bournemouth Christchurch and Poole Council Brighton and Sussex University Hospitals NHS Foundation Trust Cambridge University Hospitals NHS Foundation Trust Coventry City Council Crossroads Care South East London East Lancashire Hospitals NHS Trust Falkirk Council Gilead Hull University Teaching Hospitals Kings College Hospital Leeds Teaching Hospitals NHS Trust MSD NHS England and NHS Improvement – East Midlands (H & J) NHS Thames Valley NHS Forth Valley NHS West London NHS Tayside Newcastle Track and Trace Nottingham University Hospitals NHS Trust Oxleas NHS Foundation Trust Pilgrims Trust Practice Plus Group Health and Rehabilitation Services Limited Public Health Wales NHS Trust Royal Surrey NHS Foundation Trust Sheffield Teaching Hospitals NHS Foundation Trust St George’s University Hospitals NHS The National Health Service Commissioning Board (NHS England) The Newcastle upon Tyne Hospitals NHS Foundation Trust University Hospital Southampton NHS Foundation Trust University Hospitals Birmingham NHS Foundation Trust University Hospitals Bristol & Weston NHS Foundation Trust University Hospitals of Leicester NHS Trust University Hospitals Plymouth NHS Trust

THE HEPATITIS C TRUST Working together to eliminate hepatitis C

Registered in England and Wales Charity Number: 1104279

Registered in Scotland Charity Number: SCO39914

Registered Company Number: 5069924

72 Weston Street London SE1 3QG

hepctrust.org.uk